ETF Holdings Breakdown of VRNA

Stock Name	Verona Pharma PLC ADR
Ticker	VRNA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US9250501064
LEI	213800EVI6O6J3TIAL06

News associated with VRNA

Verona Pharma plc (NASDAQ:VRNA) Short Interest Update: Verona Pharma plc (NASDAQ:VRNA – Get Free Report) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 7,780,000 shares, a decline of 14.8% from the March 31st total of 9,130,000 shares. Based on an average daily trading volume, of 1,360,000 […] - 2025-05-05 05:35:07
Verona Pharma plc (NASDAQ:VRNA) Receives $74.67 Average PT from Analysts: Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have received an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […] - 2025-04-24 05:10:59
Verona Pharma (NASDAQ:VRNA) Coverage Initiated at Cantor Fitzgerald: Cantor Fitzgerald initiated coverage on shares of Verona Pharma (NASDAQ:VRNA – Get Free Report) in a research note issued on Monday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $80.00 price target on the stock. Cantor Fitzgerald’s price target points to a potential upside of 29.01% from the company’s previous close. VRNA […] - 2025-04-23 05:11:00
Verona Pharma plc (NASDAQ:VRNA) Stock Holdings Lessened by Legal & General Group Plc: Legal & General Group Plc cut its stake in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 62.1% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 143,216 shares of the company’s stock after selling 234,788 shares during the period. Legal & General Group Plc’s […] - 2025-04-20 07:56:53
Verona Pharma plc (NASDAQ:VRNA) Receives Average Recommendation of “Buy” from Analysts: Verona Pharma plc (NASDAQ:VRNA – Get Free Report) has earned an average rating of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective […] - 2025-03-27 06:23:07
Verona Pharma plc (NASDAQ:VRNA) Receives $66.83 Consensus Price Target from Brokerages: Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […] - 2025-03-05 06:06:47
Verona Pharma (NASDAQ:VRNA) Price Target Raised to $93.00 at Wells Fargo & Company: Verona Pharma (NASDAQ:VRNA – Free Report) had its price target boosted by Wells Fargo & Company from $74.00 to $93.00 in a research report report published on Friday,Benzinga reports. They currently have an overweight rating on the stock. Several other equities analysts have also commented on the stock. Roth Mkm started coverage on shares of […] - 2025-03-03 06:17:23
Verona Pharma (NASDAQ:VRNA) Price Target Raised to $75.00: Verona Pharma (NASDAQ:VRNA – Free Report) had its price objective increased by HC Wainwright from $60.00 to $75.00 in a report issued on Friday,Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Verona Pharma’s Q1 2026 earnings at $0.16 EPS and Q2 2026 earnings at $0.40 […] - 2025-03-03 06:17:22
Traders Purchase Large Volume of Verona Pharma Put Options (NASDAQ:VRNA): Verona Pharma plc (NASDAQ:VRNA – Get Free Report) was the recipient of some unusual options trading on Monday. Stock investors bought 3,994 put options on the company. This represents an increase of approximately 120% compared to the typical daily volume of 1,816 put options. Wall Street Analysts Forecast Growth A number of research firms have […] - 2025-02-26 06:20:55

VRNA institutional holdings

The following institutional investment holdings of VRNA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 37,520 USD 2,486,075

2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 37,520 USD 2,486,075 -4.3%

Total = 75,040 USD 4,972,150
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	37,520	USD 2,486,075
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	37,520	USD 2,486,075 -4.3%
Total =	75,040	USD 4,972,150

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.